Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.
Drugs. 2020 Apr;80(6):587-600. doi: 10.1007/s40265-020-01285-0.
Drugs. 2020.
PMID: 32162274
Free PMC article.
Clinical Trial.
Clinical and Demographic Profile of Diabetic Patients from Central India - Results from Diabetes Registry.
Pitale S, Sahasrabuddhe A, Gandhi P, Joshi P, Sakhare A, Balankhe N, Khobragade S, Sengupta S, Ambulkar S, Ganeriwal M, Shembalkar J, Naidu S.
Pitale S, et al. Among authors: shembalkar j.
Indian J Endocrinol Metab. 2022 Sep-Oct;26(5):471-477. doi: 10.4103/ijem.ijem_63_22. Epub 2022 Nov 22.
Indian J Endocrinol Metab. 2022.
PMID: 36618524
Free PMC article.
Item in Clipboard
Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.
Gomez R, Khadilkar V, Shembalkar J, Chu DM, Ko CW, Wajnrajch MP, Wang R.
Gomez R, et al. Among authors: shembalkar j.
J Pediatr Endocrinol Metab. 2024 May 9. doi: 10.1515/jpem-2023-0512. Online ahead of print.
J Pediatr Endocrinol Metab. 2024.
PMID: 38717038
Free article.
Item in Clipboard
Eruptive xanthomas.
Saoji V, Madke B, Shembalkar J, Rambhia K.
Saoji V, et al. Among authors: shembalkar j.
BMJ Case Rep. 2024 Apr 16;17(4):e260230. doi: 10.1136/bcr-2024-260230.
BMJ Case Rep. 2024.
PMID: 38627045
No abstract available.
Item in Clipboard
Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
Sahay RK, Giri R, Shembalkar JV, Gupta SK, Mohan B, Kurmi P, Kumar SR, Sawardekar VM, Mishra A, Murthy LS, Arya VV, Sonawane AR, Soni PN, Gofne SK, Karnawat SR, Rajurkar MN, Patel PM, Lakhwani LK, Mehta SC, Joglekar SJ.
Sahay RK, et al. Among authors: shembalkar jv.
Adv Ther. 2023 Jul;40(7):3227-3246. doi: 10.1007/s12325-023-02523-z. Epub 2023 May 31.
Adv Ther. 2023.
PMID: 37258803
Clinical Trial.
Item in Clipboard
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study.
Ajmani AK, Agrawal A, Prasad BLN, Basu I, Shembalkar J, Manikanth N, Subrahmanyam KAV, Srinivasa M, Chawla M, Srivastava MK, Jebasingh F, Achappa B, Agrawal RP, Pulichikkat RK, Meena R, Bhatia S, Gupta SK, Dange A, Srivastava A, Trailokya A, Shahavi V, Shende S.
Ajmani AK, et al. Among authors: shembalkar j.
Diabetes Res Clin Pract. 2019 Nov;157:107860. doi: 10.1016/j.diabres.2019.107860. Epub 2019 Sep 14.
Diabetes Res Clin Pract. 2019.
PMID: 31526825
Clinical Trial.
Item in Clipboard
Cite
Cite